A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)

The Brighton Collaboration Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO) Working Group has prepared standardized templates to describe the key considerations for the benefit-risk assessment of several vaccine platform technologies, including nucleic acid (RNA and DNA) vaccines. This pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Leav, Brett, Straus, Walter, White, Phil, Leav, Alison, Gaines, Tashawnee, Maggiacomo, Grace, Kim, Denny, Smith, Emily R., Gurwith, Marc, Chen, Robert T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181264/
https://www.ncbi.nlm.nih.gov/pubmed/35753841
http://dx.doi.org/10.1016/j.vaccine.2022.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181264/
https://www.ncbi.nlm.nih.gov/pubmed/35753841
http://dx.doi.org/10.1016/j.vaccine.2022.06.005

Ejemplares similares